Calif. firm VaxGen wins first U. S. 'BioShield' contract for anthrax vaccine

WASHINGTON (AP) - The U.S. government announced Thursday it is purchasing 75 million doses of a new-generation anthrax vaccine under an $877.5-million US contract - the first awarded through a federal program to develop and stockpile antidotes to biological and chemical weapons....More